Weston Umstead, Ph.D. Promoted to Technology & Business Development Manager for Chiral Technologies, Inc.

For Immediate Release

Weston Umstead, Ph.D. Promoted to Technology & Business Development Manager for Chiral Technologies, Inc.

WEST CHESTER, Pa (December 10, 2020) — Chiral Technologies, Inc. today announced the promotion of Weston Umstead, Ph.D., as the company’s new Technology and Business Development Director.

Umstead joined Chiral Technologies in 2016 as a chemist working in the company’s Diffinity Genomics division. He was soon promoted to Technology Manager at the end of 2018, where he managed the Chiral analytical and preparative method development projects, engaged in new technology efforts related to the core chiral business, as well as synthetic chemistry responsibilities to support Daicel Arbor Biosciences and Diffinity Genomics.

In his new role as Technology and Business Development Manager, Umstead will continue to oversee the Method Development department, providing technical support for chiral columns and technical content for marketing, in addition to taking on responsibility for sales of our Custom Chiral Separation projects. Umstead will handle all project management activities and will be the point of contact for all customer interactions.

“I’m excited that Wes has accepted this new role. Project objectives can shift quickly so it’s important to be able to pivot our efforts in the lab equally as fast. Wes’s combined role, managing both the technical and business side of the project, will greatly benefit our customers and help to ensure smooth project flow, from method development through production,” said Lisa Newton, Vice President, Sales and Marketing, Chiral Technologies, Inc.

###

About Chiral Technologies, Inc.
Chiral Technologies, Inc., the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

CHIRAL TECHNOLOGIES, INC.
1475 Dunwoody Road, Suite 310
West Chester, PA 19380 USA
(610) 594-2100
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing and Sales Services
chiral@cti.daicel.com
www.chiraltech.com

Chiral Technologies Introduces CHIRALPAK® IJ – DAICEL’s Newest Immobilized Chiral Selector

Chiral Technologies Introduces CHIRALPAK® IJ – DAICEL’s Newest Immobilized Chiral Selector offering more flexibility for screening and method development conditions.

West Chester, Pa: Chiral Technologies, Inc. today announces the addition of CHIRALPAK® IJ, its newest immobilized chiral stationary phase (CSP) from DAICEL Corporation. CHIRALPAK IJ is the immobilized version of DAICEL’s popular coated phase, CHIRALCEL® OJ.

“The addition of this new selector demonstrates DAICEL’s continuing commitment to innovation while providing our customers with the tools necessary to address the separation of challenging compounds,” says Lisa Newton, Vice President of Sales at Chiral Technologies, Inc.

CHIRALPAK IJ is a cellulose polymer derivatized with tris(4-methylbenzoate) moieties. Coated phases like CHIRALCEL OJ are susceptible to degradation from incompatible mobile phases while the immobilized CHIRALPAK IJ is:

• optimized for use under both SFC and HPLC conditions
• more chemically resilient than its coated polysaccharide phase, which allows for a longer column lifetime
• compatible with a wider range of mobile phases, which provides more thorough and complete screening and method development conditions

CHIRALPAK IJ is now available and can be found in our Product List located on our website. For more information on CHIRALPAK IJ, visit www.chiraltech.com or check out the What’s NEW section for our newest CHIRALPAK IJ application notes.

###

About Chiral Technologies
Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380 USA
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing and Sales Services
chiral@chiraltech.com
www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach – CS 80140
67404 Illkirch Cedex FRANCE
+33 (0) 3 88 79 5200
Brian Freer, Ph.D., Sales and Marketing Manager
cte@chiral.fr
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. 4A, Phase III, IKP Knowledge Park
Genome Valley, Turkapally, Shameerpet, Ranga Reddy Dist.
Hyderabad-500 078, Telangana INDIA
+91-40-2338-3700
chiral@chiral.daicel.com
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao Free Trade Zone, Post Code 200131
Shanghai, CHINA
+86 21 504 60086
chiral@ctc.daicel.com
www.daicelchiraltech.cn

Konstantine Haralampopoulos named Business Development Director, Daicel GMP Analytical Services and Pharma Standards at Chiral Technologies, Inc.

WEST CHESTER, Pa (April 6, 2020) — Chiral Technologies, Inc. today announced the hiring of Konstantine Haralampopoulos, as the company’s new Business Development Director for DAICEL GMP Analytical Services and Pharma Standards.

For the last several years, Konstantine has been working for SGS, a leader in life science testing, verification and certification solutions, as a Senior Business Development Manager. Prior to SGS, Konstantine worked at McKesson as a Senior Biologics Strategic Account Manager, Henkel as a Global Key Account Manager and Johnson and Johnson as a Sales Specialist/District Manager. For several years, Konstantine was President of his own company, Konfidant. This was a hybrid consultancy company where he provided marketing and field sales expertise to global clientele in highly visible and accountable roles.

In his new role as Business Development Director here at Chiral Technologies, Konstantine will be responsible for working closely with our colleagues at DAICEL Chiral India, DCTI, to support the pharmaceutical industry from development stage to commercial products in the Americas and Europe.

Konstantine received his Bachelor’s Degree in Biological Sciences from the University of Chicago. “Given Konstantine’s highly technical scientific background, his sales experiences and successes, and his extensive industry knowledge, we are confident he will become a strong asset to our sales team,” said Lisa Newton, Vice President, Sales, Chiral Technologies, Inc.

###

About Chiral Technologies, Inc.

Chiral Technologies, Inc., the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.  Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

Contact for Chiral Technologies:

Lorraine Evangelista, Manager, Marketing and Sales Services

Chiral Technologies, Inc.

800 North Five Points Road

West Chester, PA 19380 USA

(610) 594-2100

(800) 6-CHIRAL

levangelista@cti.daicel.com

www.chiraltech.com

 

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach – CS 80140
67404 Illkirch Cedex FRANCE

+33 (0) 3 88 79 5200

cte@cte.daicel.com

www.chiraltech.com

 

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD

Survey No.542/2, IKP Knowledge Park, Turkapally,
Shamirpet Mandal, Medchal-Malkajgiri District,
Hyderabad-500101. Telangana, INDIA
+91 84 1866 0700 or 91 84 1866 0703

chiral@chiral.daicel.com

www.chiraltech.com

 

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.

No. 32, HeXiang Road

Waigaoqiao Free Trade Zone, Post Code 200131

Shanghai, CHINA

+86 21 504 60086

chiral@ctc.daicel.com

www.daicelchiraltech.cn

Daicel logo

DAICEL Joins Partnership to Develop a DNA Vaccine Against SARS-CoV-2

DAICEL Joins Osaka University and AnGes, Inc. in a Partnership to Develop a DNA Vaccine Against SARS-CoV-2

DAICEL Corporation, the parent company of Arbor Biosciences, is providing their innovative drug delivery device, pyro-drive jet injector Actranza™ lab., for use in a joint partnership to develop a DNA vaccine against SARS-CoV-2, currently being conducted by Osaka University and Japanese company AnGes, Inc.

Overview of the Joint Partnership

  • An effort is underway for the development of a prophylactic DNA vaccine for the SARS-CoV-2 virus between Osaka University (Department of Clinical Gene Therapy/Department of Health Development and Medicine), and AnGes. Inc., utilizing AnGes, Inc.’s plasmid DNA platform.
  • The DNA vaccine production process is generally established in a shorter period of time than the production of conventional vaccines, and is being performed by Takara Bio Inc., who has the plasmid DNA production technology and facilities.
  • DAICEL has developed a gene transfer method using the Actranza™ lab. device, and is conducting research for its clinical application with Osaka University (Department of Device Application for Molecular Therapeutics/Department of Health Development and Medicine). This technology enables efficient delivery of plasmid DNA encoding antigen protein directly into cells via intradermal delivery, in order to initiate antibody production in the body.

About DNA Vaccines

DNA vaccines can be produced in a short period of time without pathogenic components. By inoculating a person with DNA plasmid encoding for a specific viral protein of the pathogen, the antigen protein is produced in the body without effects of the virus, while generating an immune response and thus further immunity against the pathogen.

About the Novel Drug Delivery Device Actranza™ lab.

Actranza™ lab. is a needle-free, jet injector driven by the instantaneous power generated from pyro combustion. The high-speed stream of liquid ejected by the device, such as a DNA vaccine, penetrates the skin and disperses directly into intradermal tissue. Because intradermal tissue contains more immunocompetent cells than muscle tissue, animal studies have shown that higher gene expression can be achieved when DNA vaccines are delivered intradermally when compared to intramuscular delivery with conventional needle injections. View details: https://www.daicel.com/en/research/actranza.html

To learn more about Actranza™ lab. contact:
Wanessa Wight, PhD
Arbor Biosciences Product Manager
US Representative for Actranza™ lab. from Daicel
Office: (734) 388-8642
Cell: (734) 773-7359

###

About Arbor Biosciences

Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost effective, user-friendly products to researchers of genetics and synthetic biology. The team at Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

IMPORTANT INFORMATION: OUR OPERATIONS DURING THE COVID-19 CRISIS

March 18, 2020

Chiral Technologies, Inc. is following the news of the Coronavirus (COVID-19) very closely, and our thoughts are with those affected. In light of the varied impact on employees and businesses, we want you to know how we are here to help.

We understand that some companies are not closing completely and vital work continues. Our Customer Service department is available to answer your order questions, ship product, and offer information on all things delivery related. Our technology team is available to answer your column or project questions.

To protect the health and safety of our employees and community during this COVID-19 outbreak, Chiral Technologies, Inc. has implemented strict guidelines to prevent workplace exposure. These guidelines include allowing employees to work from home, restrictions on business travel, and planned shift work.

Our product manufacturing procedures continue to include rigorous supply chains with multiple redundancies to ensure there is no disruption of supply of all raw materials. We will continue to assess the situation each day and update you on any changes to our operation.

Sincerely,

Chiral Technologies, Inc.

Technical questions: questions@cti.daicel.com
Customer Service: orders@cti.daicel.com

Chiral Technologies Announces 2019 Promotion

FOR IMMEDIATE RELEASE

Chiral Technologies, Inc. Appoints Lisa Newton to Vice President of Sales 

WEST CHESTER, PA, (April 23, 2019) – Chiral Technologies, Inc., part of DAICEL CORPORATION, the global market leader in enantioselective chromatography, begins 2019 by announcing the promotion of Lisa Newton to Vice President of Sales.

Lisa Newton promoted to Vice President, Sales.  Newton joined Chiral Technologies in 2003. In her former role as Sales Manager for the New England states, then later Director of Sales for North Eastern and Western regions, she was instrumental in helping the Company expand their sales activities beyond the traditional core products, and in aligning the Company’s marketing efforts with their sales goals. In this new role as Vice President, Newton will be responsible for all sales activities within Chiral Technologies, including the management of the distributor network in Canada and Latin America.

###

About Chiral Technologies

Chiral Technologies, a subsidiary of DAICEL CORPORATION, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. Learn more at www.chiraltech.com.

 

CHIRAL TECHNOLOGIES INC.

800 North Five Points Road

West Chester, PA 19380 USA

(800) 6-CHIRAL

Lorraine Evangelista, Manager, Marketing and Sales Services

chiral@cti.daicel.com

www.chiraltech.com

Arbor biosciences logo

Chiral Technologies, Inc. Acquires Arbor Biosciences

FOR IMMEDIATE RELEASE

Chiral Technologies, Inc. Acquires Arbor Biosciences – Increasing Their Portfolio for the Biopharma Industry

WEST CHESTER, PA, (January 10, 2019) – Chiral Technologies, Inc. part of DAICEL CORPORATION, the global market leader in enantioselective chromatography, is pleased to announce the acquisition of Arbor Biosciences of Ann Arbor, MI.

Arbor Biosciences (formerly MYcroarray), founded in 2006 by University of Michigan Prof. Erdogan Gulari and Dr. Jean-Marie Rouillard, has evolved over the years from producing custom DNA microarrays to generating oligonucleotide pools using its proprietary massively parallel DNA synthesis technology. The primary growth driver is their myBaits targeted sequencing panels, both custom and catalog offerings, which are complemented by the services division to provide an end-to-end solution for their clients. Recently they have expanded into synthetic biology with a cell-free expression system using linear DNA as template for rapid protein expression.

“As we diversify our product portfolio to serve the needs of biopharma, Arbor Biosciences delivers the molecular biology foundation to fuel that growth” stated Joseph Barendt, Ph.D., President of Chiral Technologies, Inc.

“This is a very exciting time as we are moving Arbor Biosciences to the next level” stated Jean-Marie Rouillard, CSO and co-founder at Arbor Biosciences “The additional investments by DAICEL/Chiral will help accelerate our growth and deliver innovative, cost-effective solutions to our clients in the biotechnology and life sciences markets faster than previously planned. It will also open up access to new markets.”

Arbor Biosciences will continue to operate at its current location in Ann Arbor, MI as a wholly owned subsidiary of Daicel Corporation and managed by Chiral Technologies, Inc. The entire Arbor Biosciences team will remain in place, including co-founders Gulari and Rouillard.

About Chiral Technologies
Chiral Technologies, a subsidiary of DAICEL CORPORATION, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. Learn more at www.chiraltech.com.

About Arbor Biosciences
Arbor Biosciences is a development and manufacturing company founded by scientists to serve the genomics, cytogenetics and synthetic biology communities. The Arbor Biosciences team is passionate and determined to deliver cost-effective, user-friendly products to academic and industry researchers. It prides itself on providing exceptional customer service and timely technical support to new or advanced users. Arbor Biosciences scientists routinely collaborate with customers and research partners to develop innovative solutions to address their unique applications. Learn more at www.arborbiosci.com.

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380 USA
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing and Sales Services
chiral@chiraltech.com
www.chiraltech.com

ARBOR BIOSCIENCES
5840 Interface Drive
Ann Arbor, MI 48103 USA
(734) 998 0751
info@arborbiosci.com
www.arborbiosci.com

Chiral Technologies Introduces CHIRALPAK IH

Chiral Technologies Introduces CHIRALPAK® IH – The Newest Immobilized Chiral Selector from DAICEL Corporation

WEST CHESTER, Pa. (March 8, 2018) — Chiral Technologies announces the newest immobilized chiral stationary phase (CSP) from DAICEL, CHIRALPAK® IH. This new CSP, the immobilized version of DAICEL’s popular CHIRALPAK AS, provides greater solvent versatility, robustness, and loading capacity.

The addition of this new selector demonstrates DAICEL’s continuing commitment to innovation and, to providing our customers with the best way to simplify their work and increase their success.

###

About Chiral Technologies
Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at http://www.chiraltech.com/ and http://www.daicelchiraltech.cn/

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380 USA
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing and Sales Services
chiral@chiraltech.com
http://www.chiraltech.com/

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach – CS 80140
67404 Illkirch Cedex FRANCE
+33 (0) 3 88 79 5200
Brian Freer, Ph.D., Sales and Marketing Manager
cte@chiral.fr
http://www.chiraltech.com/

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. 4A, Phase III, IKP Knowledge Park
Genome Valley, Turkapally, Shameerpet, Ranga Reddy Dist.
Hyderabad-500 078, Telangana INDIA
+91-40-2338-3700
chiral@chiral.daicel.com
http://www.chiraltech.com/

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao Free Trade Zone, Post Code 200131
Shanghai, CHINA
+86 21 504 60086
chiral@ctc.daicel.com
http://www.daicelchiraltech.cn/

MEDIA CONTACT
Stephanie N. Kuhla
(847) ADVANTA
Advanta Advertising Design | Interactive, LLC
skuhla@advantadesigngroup.com

CTI Signs Exclusive Distributor Agreement with Biotecnology Latina

Chiral Technologies, Inc. Signs Exclusive Distributor Agreement with Biotecnology Latina S.R.L. of Lima, PERU

WEST CHESTER, Pa. (July 24, 2017) — Chiral Technologies, part of DAICEL CORPORATION, the global market leader in enantioselective chromatography, is pleased to announce that it has signed an exclusive agreement with Biotecnology Latina S.R.L. based in the Surquillo district of Lima, Peru.

Joseph Barendt, Ph.D., President of Chiral Technologies Inc. commented “with the addition of Biotecnology Latina we are well positioned now to capitalize on the extensive growth we are seeing in North and South America with our laboratory products line.”

“Biotecnology Latina is a recognized leader in the biotechnology and chromatography equipment market in Peru. Access to Biotecnology Latina will greatly extend our sales and services,” commented David W. Ellis, Director of International Sales for Chiral Technologies, Inc.

Mr. Ernesto Castillo, Business Manager of Biotecnology Latina said that “this exclusive arrangement with Chiral Technologies allows us to expand our offering of quality chiral products to all our current and potential customers.”
###

About Biotecnology Latina S.R.L.
Biotecnology Latina is dedicated to the marketing, distribution and sales of laboratory equipment for scientific research and diagnostics in the fields of biology, molecular biology, chemistry, and chromatography.

About Chiral Technologies, Inc.
Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing Services
chiral@chiraltech.com
www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach – CS 80140
67404 Illkirch Cedex France
+33 (0) 3 88 79 5200
Brian Freer, Ph.D., Sales and Marketing Manager
cte@chiral.fr
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. 4A, Phase III, IKP Knowledge Park
Genome Valley, Turkapally, Shameerpet, Ranga Reddy
Dist. Hyderabad-500 078, Telangana
+91-40-2338-3700
chiral@chiral.daicel.com
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao Free Trade Zone
Post Code 200131
Shanghai, China
+86 21 504 60086
chiral@ctc.daicel.com
www.daicelchiraltech.cn

MEDIA CONTACT
Stephanie N. Kuhla
(847) ADVANTA
Advanta Advertising Design | Interactive, LLC
skuhla@advantadesigngroup.com

Chiral Technologies launches sub-2 µm immobilized CSPs

Chiral Technologies Launches sub-2 Micron Immobilized Chiral Columns From Daicel Corporation.

WEST CHESTER, Pa. (November 17, 2016) – Chiral Technologies announces the availability of new sub-2 µm immobilized chiral stationary phases (CSP), a first in the industry.

Daicel Corporation has developed the first two products in its new immobilized sub-2 µm polysaccharide selector series. CHIRALPAK® IA-U and CHIRALPAK IC-U have been designed for use with UHPLC systems for ultrafast and efficient separations of enantiomers.

Ultrafast separations of chiral compounds enable rapid high-throughput screening and optimized method development, which leads to a significant decrease in analysis and chemical development time.

“Daicel Corporation continues its commitment to provide new and innovative chiral chromatography products, thereby providing our customers with unique and timely solutions to advance their workflow in cost-effective ways” said Joe Barendt, Ph.D., President of Chiral Technologies, Inc.

###

About Chiral Technologies, Inc.

Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies, Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at www.chiraltech.com and www.daicelchiraltech.cn.

CHIRAL TECHNOLOGIES INC.
800 North Five Points Road
West Chester, PA 19380
(800) 6-CHIRAL
Lorraine Evangelista, Manager, Marketing Services
chiral@chiraltech.com
www.chiraltech.com

CHIRAL TECHNOLOGIES EUROPE
Parc d’Innovation – 160, Bd Gonthier d’Andernach CS 80140
67404 Illkirch Cedex France
+33 (0) 3 88 79 52 00
Brian Freer, Ph.D., Business Marketing Manager
cte@chiral.fr
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (INDIA) PVT. LTD
Lab No. A4, Phase III, IKP Knowledge Park
Genome Valley, Turkapally, Shameerpet, Ranga Reddy Dist.
Hyderabad-500 078, Telangana
+91 40 2338 3700
chiral@chiral.daicel.com
www.chiraltech.com

DAICEL CHIRAL TECHNOLOGIES (CHINA) CO., LTD.
No. 32, HeXiang Road
Waigaoqiao Free Trade Zone
Post Code 200131
Shanghai, China
+86 21 504 60086
chiral@ctc.daicel.com
www.daicelchiraltech.cn

MEDIA CONTACT
Stephanie N. Kuhla
(847) ADVANTA
Advanta Advertising, LLC
skuhla@advantadna.com